Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 9 - Number 5

Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)

, 9(5): 595 - 607

P. Heffeter, A. Popovic-Bijelic, P. Saiko, R. Dornetshuber, U. Jungwirth, N. Voevodskaya, D. Biglino, M. A. Jakupec, L. Elbling, M. Micksche, T. Szekeres, B. K. Keppler, A. Graslund and W. Berger


DOI: 10.2174/156800909789056962



P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)

, 9(5): 617 - 625

C. Tripodo, A. M. Florena, P. Macor, A. Di Bernardo, R. Porcasi, C. Guarnotta, S. Ingrao, M. Zerilli, E. Secco, M. Todaro, F. Tedesco and V. Franco


DOI: 10.2174/156800909789056971





Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)

, 9(5): 675 - 689

K. V. Gleixner, M. Mayerhofer, A. Vales, A. Gruze, G. Hormann, S. Cerny-Reiterer, E. Lackner, E. Hadzijusufovic, H. Herrmann, A. K. Iyer, M.-T. Krauth, W. F. Pickl, B. Marian, R. Panzer-Grumayer, C. Sillaber, H. Maeda, C. Zielinski and P. Valent


DOI: 10.2174/156800909789057024


Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways

, 9(5): 690 - 704

M. Caraglia, M. Marra, P. Tagliaferri, S. W.J. Lamberts, S. Zappavigna, G. Misso, F. Cavagnini, G. Facchini, A. Abbruzzese, L. J. Hofland and G. Vitale


DOI: 10.2174/156800909789056980



Related Journals

Related eBooks

eBooks Catalog